HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: db07-0981v1 57/9/2393    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Johansson, U. Articles by Magnusson, P. U. PubMed PubMed Citation Articles by Johansson, U. Articles by Magnusson, P. U. Related Collections Related Article Social Bookmarking                What's this?

Formation of Composite Endothelial Cell–Mesenchymal Stem Cell Islets

A Novel Approach to Promote Islet Revascularization

¹ Division of Clinical Immunology, the Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden
² Centre de Recherche Public-Santé, NorLux Neuro-Oncology Laboratory, Val Fleuri, Luxembourg, Luxembourg

Corresponding author: Ulrika Johansson, ulrika.johansson{at}klinimm.uu.se

OBJECTIVE—Mesenchymal stem cells (MSCs) contribute to endothelial cell (EC) migration by producing proteases, thereby paving the way into the tissues for ECs. MSCs were added to our previously described composite EC islets as a potential means to improve their capacity for islet angiogenesis.

RESEARCH DESIGN AND METHODS—Human islets were coated with primary human bone marrow–derived MSCs and dermal microvascular ECs. The capacity of ECs, with or without MSCs, to adhere to and grow into human islets was analyzed. The survival and functionality of these composite islets were evaluated in a dynamic perifusion assay, and their capacity for angiogenesis in vitro was assessed in a three-dimensional fibrin gel assay.

RESULTS—ECs proliferated after culture in MSC-conditioned medium, and MSCs improved the EC coverage threefold compared with EC islets alone. Islet survival in vitro and the functionality of the composite islets after culture were equal to those of control islets. The EC-MSC islets showed a twofold increase in total sprout formation compared with EC islets, and vascular sprouts emanating from the EC-MSC–islet surface showed migration of ECs into the islets and also into the surrounding matrix, either alone or in concert with MSCs.

CONCLUSIONS—EC proliferation, sprout formation, and ingrowth of ECs into the islets were enhanced by MSCs. The use of composite EC-MSC islets may have beneficial effects on revascularization and immune regulation. The technique presented allows for pretreatment of donor islets with recipient-derived ECs and MSCs as a means of improving islet engraftment.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article:

Revascularization of Transplanted Islets: Can It Be Improved?

Marcela Brissova and Alvin C. Powers
Diabetes 2008 57: 2269-2271. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				M. Brissova and A. C. Powers Revascularization of Transplanted Islets: Can It Be Improved? Diabetes, September 1, 2008; 57(9): 2269 - 2271. [Full Text] [PDF]